PDCD1 and neoplasm: PD-L1 is a transmembrane protein that suppresses immune responses by binding to two inhibitory receptors, PD-1 and B7-1 (CD80), and it is strongly expressed on the surface of tumor and non-transformed cells in the tumor microenvironment [68].